Creating tools to understand natural pain relief in the brain
Design of genetically encoded sensors for detecting endogenous opioid peptides
This work aims to develop new ways to see how the body's own pain-relieving chemicals work in the brain, hoping to inspire safer pain medicines.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11126698 on NIH RePORTER |
What this research studies
Current strong pain medications, like opioids, are very effective but come with serious side effects such as addiction and breathing problems. These issues arise because these drugs aren't precise enough in how they act on the brain's pain pathways. Our bodies naturally produce opioid-like chemicals that don't cause these severe side effects, but we don't fully understand how they work. This project focuses on designing special tools, called genetically encoded sensors, to precisely detect when and where these natural pain relievers are released in the brain. By observing these natural processes with greater detail, we hope to uncover new strategies for creating pain medications that are both powerful and much safer.
Who could benefit from this research
Good fit: This foundational research does not directly involve patients, but future clinical applications could benefit individuals suffering from chronic pain or those at risk of opioid addiction.
Not a fit: Patients seeking immediate treatment or direct participation in a clinical trial will not find a direct benefit from this basic science project.
Why it matters
Potential benefit: If successful, this work could lead to a deeper understanding of natural pain relief, potentially paving the way for new, safer pain medications with fewer side effects than current opioids.
How similar studies have performed: While current methods for detecting these brain chemicals exist, this approach aims to develop novel sensors with significantly higher precision than previously available techniques.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Wang, Wenjing — University of Michigan at Ann Arbor
- Study coordinator: Wang, Wenjing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.